DOPAMINE D3 RECEPTOR LIGANDS FOR TREATMENT OF SUBSTANCE ABUSE

用于治疗药物滥用的多巴胺 D3 受体配体

• 批准号: 8172840
• 负责人: ROGER D SPEALMAN
• 金额: $ 1.81万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8172840
• 关键词: Agonist; Computer Retrieval of Information on Scientific Projects Database; Disease; Funding; Grant; Institution; Ligands; Research; Research Personnel; Resources; Role; Source; United States National Institutes of Health; dopamine D3 receptor; receptor; stimulant abuse; substance abuse treatment

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project investigates the role of dopamine D3 receptor mechanisms in stimulant abuse and the potential utility of D3 receptor antagonists and partial agonists for the treatment of substance abuse disorders.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 该项目研究了多巴胺D3受体机制在刺激性滥用方面的作用以及D3受体拮抗剂和部分激动剂在治疗药物滥用障碍方面的潜在效用。